Takeda Pharmaceutical (TAK) Gets Priority Review. Can Zasocitinib Win in Psoriasis?

This is a summary. Read the complete story at Yahoo Finance below.

Related Stories

markets24 minutes ago

The hottest part of the AI trade could be turning into its biggest weakness

While stock investors celebrate booming demand for chips and servers, credit markets are flagging risky contracts and rising debt costs.

MarketWatch

markets25 minutes ago

Forget Elon Musk and Jeff Bezos: The ‘everywhere millionaires’ created the blueprint for regular people to get rich in America

Owen Zidar and Eric Zwick spent a decade mining tax data to identify an under-the-radar class of American wealth.

MarketWatch

marketsabout 2 hours ago

Meta’s stock is enjoying its best month in 13 years thanks to the company’s hot new AI assistant

Muse is gaining popularity and helping convince investors that Meta’s AI bets are paying off.

MarketWatch